Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA)

CUSIP: 92337R101

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 signals
Share change
+773,192
Put/Call ratio
139%
SEC-reported price per share
$16.05
Number of holders
76
Value change
+$42,587,635
Number of buys
50
Open additional details 1 more signal available
Number of sells
33
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
71,530,793

Security key

92337R101

Report period

Q2 2023

Institutions

76

Top holders

10

Ownership snapshot

Top reported holders of VERA - Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Sofinnova Venture Partner...
Disclosed value leader
Sofinnova Venture Partner...
Comparable rows
0/15
Latest evidence
31 Mar 2023
3/4/5 13F Highest disclosed value: $62,408,808 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Sofinnova Venture Partners X, L.P. has the largest disclosed position value at $62.41M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Sofinnova Venture Partners X, L.P.'s linked filing trail.
Disclosed position value Top 5
Sofinnova Venture Partners X, L.P. $62.41M
Abingworth LLP $53.28M
Carlyle Group Inc. $53.28M
Longitude Capital Partners IV, LLC $30.86M
Longitude Prime Partners, LLC $30.86M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Sofinnova Venture Partners X, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$62,408,808
3,467,156 shares
— 06 Feb 2023
Abingworth LLP
3/4/5
10%+ Owner
—
mixed-class rows
$53,284,158
2,970,156 shares
mixed-class rows
— 13 May 2021
Carlyle Group Inc.
3/4/5 13F
10%+ Owner · Company
—
denominator unverified
$53,284,158
2,960,231 shares
— 17 Aug 2022
Longitude Capital Partners IV, LLC
3/4/5
10%+ Owner
—
denominator unverified
$30,857,130
1,714,285 shares
— 06 Feb 2023
Longitude Prime Partners, LLC
3/4/5
10%+ Owner
—
denominator unverified
$30,857,130
1,714,285 shares
— 06 Feb 2023
Emster Kurt von
3/4/5
Director
—
mixed-class rows
$53,605,062
2,987,984 shares
mixed-class rows
— 17 May 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
76
Shares
38,127,621
Rows available
76
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
69
Q2 2023 holders
76
Holder diff
7
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .